ST LOUIS--(BUSINESS WIRE)--PierianDx, the forerunner in clinical genomic informatics, announced today that Molecular Diagnostics Laboratories (MDL) has standardized on its leading bioinformatics software platform in order to rapidly launch its BRCA1/2 genomic testing program.
MDL, based in Covington, KY, will utilize the PierianDx Clinical Genomicist Workstation™ 3.0 to jump-start its BRCA testing program. Branded BRCAware™, the program will operate in all 50 states through MDL’s distribution channel.
Help employers find you! Check out all the jobs and post your resume.
MDL, based in Covington, KY, will utilize the PierianDx Clinical Genomicist Workstation™ 3.0 to jump-start its BRCA testing program. Branded BRCAware™, the program will operate in all 50 states through MDL’s distribution channel.
Help employers find you! Check out all the jobs and post your resume.
